Operating Lease, Liability in USD of LIGAND PHARMACEUTICALS INC from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Ligand Pharmaceuticals Inc quarterly Operating Lease, Liability history and change rate from Q1 2019 to Q4 2024.
  • Ligand Pharmaceuticals Inc Operating Lease, Liability for the quarter ending 31 Dec 2024 was $7.08M, a 15% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $7.08M +$923K +15% 31 Dec 2024 10-K 28 Feb 2025
Q4 2023 $6.16M -$4.85M -44% 31 Dec 2023 10-K 29 Feb 2024
Q4 2022 $11M -$6.54M -37.3% 31 Dec 2022 10-K 28 Feb 2023
Q3 2022 $37.2M +$23.6M +173% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $29.6M 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $18.7M 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $17.5M +$10M +133% 31 Dec 2021 10-K 28 Feb 2022
Q3 2021 $13.6M 30 Sep 2021 10-Q 09 Nov 2021
Q4 2020 $7.53M -$3.68M -32.9% 31 Dec 2020 10-K 24 Feb 2021
Q4 2019 $11.2M 31 Dec 2019 10-K 27 Feb 2020
Q3 2019 $10.9M 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $11.5M 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $5.51M 31 Mar 2019 10-Q 09 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.